+ Site Statistics
References:
52,572,879
Abstracts:
28,705,754
PMIDs:
27,750,366
DOIs:
25,464,004
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The German Chronic Kidney Disease (GCKD) study: design and methods



The German Chronic Kidney Disease (GCKD) study: design and methods



Nephrology, Dialysis, Transplantation 27(4): 1454-1460



Chronic kidney disease (CKD) is increasingly recognized as a global health problem. The conditions leading to CKD, the health impact of CKD and the prognosis differ markedly between affected individuals. In particular, renal failure and cardiovascular mortality are competing risks for CKD patients. Opportunities for targeted intervention are very limited so far and require an improved understanding of the natural course of CKD, of the risk factors associated with various clinical end points and co-morbidities as well as of the underlying pathogenic mechanisms. The German Chronic Kidney Disease (GCKD) study is a prospective observational national cohort study. It aims to enrol a total of 5000 patients with CKD of various aetiologies, who are under nephrological care, and to follow them for up to 10 years. At the time of enrolment, male and female patients have an estimated glomerular filtration rate (eGFR) of 30-60 mL/min×1.73 m2 or overt proteinuria in the presence of an eGFR>60 mL/min×1.73 m2. Standardized collection of biomaterials, including DNA, serum, plasma and urine will allow identification and validation of biomarkers associated with CKD, CKD progression and related complications using hypothesis-driven and hypothesis-free approaches. Patient recruitment and follow-up is organized through a network of academic nephrology centres collaborating with practising nephrologists throughout the country. The GCKD study will establish one of the largest cohorts to date of CKD patients not requiring renal replacement therapy. Similarities in its design with other observational CKD studies, including cohorts that have already been established in the USA and Japan, will allow comparative and joint analyses to identify important ethnic and geographic differences and to enhance opportunities for identification of relevant risk factors and markers.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036370467

Download citation: RISBibTeXText

PMID: 21862458

DOI: 10.1093/ndt/gfr456


Related references

Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study. Nephrology, Dialysis, Transplantation 30(4): 613-621, 2016

Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study. Plos One 13(8): E0202604, 2018

Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort. Nephrology, Dialysis, Transplantation 30(3): 441-451, 2016

Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort. Bmc Nephrology 17(1): 59, 2017

Do telomeres have a higher plasticity than thought? Results from the German Chronic Kidney Disease (GCKD) study as a high-risk population. Experimental Gerontology 72: 162-166, 2016

Heart failure in a cohort of patients with chronic kidney disease: the GCKD study. Plos One 10(4): E0122552, 2016

Association of relative telomere length with cardiovascular disease in a large chronic kidney disease cohort: the GCKD study. Atherosclerosis 242(2): 529-534, 2016

Glomerulocystic kidney disease (GCKD) associated with Henoch-Schoenlein purpura: a case report and a review of adult cases of GCKD. Clinical Nephrology 57(5): 386-391, 2002

Asymmetric dimethlyarginine directly promotes chronic kidney disease progression: Evidence from a mendelian randomization approach in the GCKD study. Atherosclerosis 252: E256-E257, 2016

Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods. Hypertension Research 31(6): 1101-1107, 2008

Chinese cohort study of chronic kidney disease: design and methods. Chinese Medical Journal 127(11): 2180-2185, 2015

Indian chronic kidney disease study: Design and methods. Nephrology 22(4): 273-278, 2016

KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methods. Bmc Nephrology 15: 80, 2014

Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clinical Journal of the American Society of Nephrology 1(5): 1006-1015, 2007

Chronic kidney disease - determinants of progression and cardiovascular risk. PROGREDIR cohort study: design and methods. Sao Paulo Medical Journal 135(2): 133-139, 2017